Mucoepidermoid carcinoma of salivary glands in the pediatric age group: 18 clinical cases, including 11 second malignant neoplasms
✍ Scribed by Pierre Olivier Védrine; Laurent Coffinet; Stéphane Temam; Karine Montagne; Michel Lapeyre; Odile Oberlin; Daniel Orbach; Claude Simon; Danièle Sommelet
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 104 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background.
Salivary gland tumors represent 1% of head and neck tumors, with only 5% of these occurring in patients younger than 20 years. Mucoepidermoid carcinoma (MEC) is one of the most frequent salivary gland cancers among adults and children.
Methods.
This survey was conducted among 34 French pediatric oncology departments. From 1980 to 2000, 18 cases were reported.
Results.
Treatment included surgery or radiotherapy, or both. The 5‐year survival rate was 93.7%. Eleven patients had been previously treated by radiotherapy and/or chemotherapy for a first malignant tumor, specifically, lymphoid leukemia (n = 4), lymphoma (n = 3), brain tumor (n = 2), sarcoma (n = 1), and retinoblastoma (n = 1).
Conclusions.
MEC is very rare in the pediatric age group. Treatment involves surgical removal of the tumor plus radiotherapy, according to histologic staging. MEC has a good prognosis in young patients. The survival rate does not differ in the subgroup of patients with MEC as a secondary tumor. © 2006 Wiley Periodicals, Inc. Head Neck, 2006